Activation of the POSTN+ CAF-CCL3+ macrophage axis correlated with poor survival and reduced response to ICB therapy.<h4>Conclusions</h4>This study defines a spatially organized stromal-immune signaling axis that drives immune exclusion and immunotherapy resistance in ccRCC. This evidence concerns the gene CCL3 and nonpapillary renal cell carcinoma.